Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04524767 · ClinicalTrials.gov registry record · NA
Depression Screening in Black Churches
A NA study of Depression, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 505
- Enrollment target
- 2
- Study locations
NCT04524767: Completed NA study of Depression, sponsored by Columbia University.
NCT04524767 is a NA study of Depression that has completed, run by Columbia University. The registered enrollment target is 505 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (36% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04524767, a NA study of Depression, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 505 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall aim of this study is to employ Community Health Workers (CHWs) to screen for depression in 30 Black churches and compare the effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) (Intervention arm) to Referral As Usual (Control arm) on treatment engagement for depression. The investigators will assess patient-level outcomes (Mental-Health Related Quality of Life and depressive symptoms) at 3- and 6-months post-screening and conduct a mixed-methods process evaluation to assess multi-level facilitators and barriers of screening uptake.
Primary Outcome
Attendance at a depression-related clinical visit for which the subject reported receiving information, referral, counseling, or medication for depression.
Conditions Studied
Interventions
- BEHAVIORAL SBIRT
- BEHAVIORAL Referral as Usual
Study Locations (2)
New York
- Columbia University Irving Medical Center Center - New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
What the finished NCT04524767 record still lists
NCT04524767 is an interventional study that assigns participants to a tested intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which SBIRT is the first listed.
NCT04524767 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04524767 about?
NCT04524767 is a clinical study titled "Depression Screening in Black Churches". The overall aim of this study is to employ Community Health Workers (CHWs) to screen for depression in 30 Black churches and compare the effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) (Intervention arm) to Referral As Usual (Control arm) on treatment engagement for...
What is the current status of trial NCT04524767?
This trial is currently completed. It is a NA study. The enrollment target is 505 participants. The study started on 2021-08-01. Estimated completion is 2025-07-18.
What conditions does trial NCT04524767 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT04524767?
The interventions under investigation include: SBIRT (BEHAVIORAL), Referral as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT04524767?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04524767 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04524767's enrollment target sits among peer trials
505 78th of 679 higher than 602 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy